Charles River Lbrtrs ntrntl Inc (CRL) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB +1,23%	1 096,39	+13,35	+1,23%	—	1 083,04	1 082,63	1 099,01	1 080,59	—	—
SIXC Communications SIXC Communications	SIXC +1,17%	609,41	+7,03	+1,17%	—	602,38	602,38	609,75	599,75	—	—
SIXE Energy SIXE Energy	SIXE +1,04%	1 255,76	+12,93	+1,04%	—	1 242,83	1 229,31	1 257,33	1 220,51	—	—
SIXI Industrials SIXI Industrials	SIXI +2,59%	1 758,20	+44,38	+2,59%	—	1 713,82	1 715,47	1 759,93	1 715,47	—	—
SIXM Financials SIXM Financials	SIXM +0,47%	643,02	+3,03	+0,47%	—	639,99	636,98	643,77	631,81	—	—
SIXR Staples SIXR Staples	SIXR +1,69%	851,59	+14,13	+1,69%	—	837,46	840,30	852,15	840,30	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +1,60%	217,64	+3,42	+1,60%	—	214,22	214,22	217,69	214,05	—	—
SIXT Technology SIXT Technology	SIXT +0,36%	3 215,78	+11,40	+0,36%	—	3 204,38	3 215,04	3 217,27	3 159,90	—	—
SIXU Utilities SIXU Utilities	SIXU +2,28%	946,49	+21,11	+2,28%	—	925,38	927,91	948,11	927,91	—	—
SIXV Health care SIXV Health care	SIXV +2,23%	1 474,92	+32,21	+2,23%	—	1 442,71	1 443,01	1 477,90	1 443,01	—	—
SIXY Discretionary SIXY Discretionary	SIXY +1,40%	2 394,29	+32,95	+1,40%	—	2 361,34	2 391,00	2 399,18	2 354,52	—	—

CRL:NYSE

Charles River Lbrtrs ntrntl Inc

166,94 USD

+1,89%

(+3,10) 1 D

30. apr., 16:00:00 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for CRL …

Åpne

163,15 USD

Høy

167,32 USD

Lav

161,95 USD

Markedsverdi

8,21 mrd.

Snittvolum

846,88k

Volum

486,66k

52 u høy

228,88 USD

52 u lav

107,60 USD

EPS

−2,91 USD

Beta

1,61

Utestående aksjer

49,34 mill.

Antall ansatte

19k

Relaterte aksjer

Thermo Fisher Scientific

Nyhetssaker

Fra kilder på nettet

Yahoo! Finance Canada

for 6 timer siden

Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Stock Titan

for 8 timer siden

First commercial rat IVF service targets breeding bottlenecks

AD HOC NEWS

for 10 timer siden

Charles River Laboratories Stock: Q1 2026 Earnings Release Scheduled for April 30

MarketWatch

for 22 timer siden

Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors

Profil

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia

Om Charles River Lbrtrs ntrntl Inc

Administrerende direktørJames C. Foster

Ansatte19k

Grunnlagt1947

HovedkontorWilmington, Massachusetts, USA

Sektor-

Nettstedcriver.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	984,17 mill.	1,03 mrd.	1,00 mrd.	994,23 mill.
Varekostnad	644,07 mill.	648,60 mill.	652,72 mill.	665,36 mill.
Direkte driftskostnader	644,07 mill.	648,60 mill.	652,72 mill.	665,36 mill.
Utgifter til forskning og utvikling	-	-	-	-
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	176,32 mill.	185,82 mill.	173,64 mill.	192,02 mill.
Driftskostnader	206,08 mill.	211,51 mill.	201,05 mill.	284,04 mill.
Totale driftskostnader	850,15 mill.	860,10 mill.	853,77 mill.	949,40 mill.
Driftsinntekter	134,01 mill.	172,03 mill.	151,08 mill.	44,83 mill.
Andre ikke-operasjonelle inntekter	−3,61 mill.	154,00k	−22,62 mill.	27,72 mill.
EBT inkludert uvanlige elementer	35,98 mill.	71,42 mill.	87,20 mill.	−294,10 mill.
EBT uten uvanlige elementer	95,32 mill.	143,32 mill.	104,48 mill.	35,18 mill.
Kostnad for inntektsskatt	10,10 mill.	18,72 mill.	31,64 mill.	−17,81 mill.
Faktisk avgiftssats	28,07 %	26,22 %	36,29 %	6,06 %
Andre driftskostnader	-	-	-	-
Nettoinntekt	25,47 mill.	52,33 mill.	54,42 mill.	−276,56 mill.
Netto fortjenestemargin	2,59 %	5,07 %	5,42 %	−27,82 %
Resultat per aksje	2,34	3,12	2,43	2,39
Rente- og investeringsinntekter	1,40 mill.	1,10 mill.	1,42 mill.	1,02 mill.
Rentekostnader	−27,88 mill.	−29,97 mill.	−25,40 mill.	−23,78 mill.
Netto rentekostnader	−26,48 mill.	−28,87 mill.	−23,98 mill.	−22,76 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	218,88 mill.	327,04 mill.	165,25 mill.	169,61 mill.
Gevinst eller tap ved salg av eiendeler	−3,38 mill.	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning